Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways.
Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways.
复制标题
Vaspin 通过 PI3K/Akt 和 NF-kappa B 信号通路对胰腺 β 细胞分泌的影响
DOI:
10.1371/journal.pone.0189722
复制
发表时间:
2017
期刊:
影响因子:
3.7
通讯作者:
Li N
中科院分区:
文献类型:
--
作者:
Liu S;Li X;Wu Y;Duan R;Zhang J;Du F;Zhang Q;Li Y;Li N
Vaspin (visceral adipose tissue-derived serine protease inhibitor) is a recently discovered adipokine that has been implicated in diabetes mellitus and other metabolic disorders. However, the effects of vaspin on pancreatic β cell function and related mechanisms are not fully understood. Thus, the present study was performed to investigate the effects of vaspin on pancreatic β cell function and the potential underlying mechanisms. Both in vitro (rat insulinoma cells, INS-1) and in vivo (high fat diet fed rats) experiments were conducted. The results showed that vaspin significantly increased INS-1 cell secretory function. Potential mechanisms were explored using inhibitors, western blot and real-time PCR techniques. We found that vaspin increased the levels of IRS-2 mRNA and IRS-2 total protein, while decreased the serine phosphorylation level of IRS-2 protein. Moreover, vaspin increased the Akt phosphorylation protein level which was reversed by PI3K inhibitor ly294002. In addition, vaspin increased the phosphorylation levels of mTOR and p70S6K, which was inhibited by rapamycin. Meanwhile, we found that the NF-κB mRNA and protein levels were reduced after vaspin treatment, similar to the effect of NF-κB inhibitor TPCK. Furthermore, vaspin increased the glucose stimulated insulin secretion (GSIS) level, lowered blood glucose level and improved the glucose tolerance and insulin sensitivity of high fat diet fed rats. Hyperglycemic clamp test manifested that vaspin improved islet β cell function. Together, these findings provide a new understanding of the function of vaspin on pancreatic β cell and suggest that it may serve as a potential agent for the prevention and treatment of type 2 diabetes.
登录
查看更多内容
影响因子:
3.7
作者:
Cui W;Ma J;Wang X;Yang W;Zhang J;Ji Q
通讯作者:
Ji Q
DOI:
10.1083/jcb.200403069
发表时间:
2004-07-19
期刊:
The Journal of cell biology
影响因子:
--
作者:
Harrington LS;Findlay GM;Gray A;Tolkacheva T;Wigfield S;Rebholz H;Barnett J;Leslie NR;Cheng S;Shepherd PR;Gout I;Downes CP;Lamb RF
通讯作者:
Lamb RF
影响因子:
5.3
作者:
Assmann, Anke;Ueki, Kohjiro;Kulkarni, Rohit N.
通讯作者:
Kulkarni, Rohit N.
影响因子:
5.1
作者:
KAWANO, K;HIRASHIMA, T;NATORI, T
通讯作者:
NATORI, T
影响因子:
7.7
作者:
Donath, MY;Ehses, JA;Reinecke, M
通讯作者:
Reinecke, M